Hepatocellular Cancer

Oncology·MeSH: Liver Neoplasms

6 drugs in development·4 companies·7 clinical trials

Drug Pipeline by Phase

Phase 1(3)

Drug	Company
abbv-324	AbbVie Inc. (ABBV)
autologous genetically modified afpᶜ³³²t cells	Adaptimmune Therapeutics PLC (ADAP)
lenvatinib	AbbVie Inc. (ABBV)

Unknown(1)

Drug	Company
cabozantinib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)

Phase 4(2)

Drug	Company
Pregabalin + Amantadine	ENANTA PHARMACEUTICALS INC (ENTA)
Pregabalin + Duloxetine	ENANTA PHARMACEUTICALS INC (ENTA)

BioSniper tracks 6 drugs in development for Hepatocellular Cancer across 4 companies.

There are 7 clinical trials targeting Hepatocellular Cancer tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.